The #1 DNA Stock Leading the Genomic Revolution?

Precision medicine just took a HUGE step forward… CRISPR gene-editing technology was used on humans for the first time. Biotech company Intellia Therapeutics Inc. (Nasdaq: NTLA) achieved the milestone in a clinical trial in June. CRISPR editing was used to treat people with a rare protein disorder. Not only was the treatment safe, but preliminary … Read More